Home

Rafael Bejar

CIK 1797382 · Sr VP & Chief Medical Officer · last filed 2026-07-01

Rafael Bejar is a Sr VP & Chief Medical Officer who has filed 9 SEC Form 4 insider transactions across 1 company since 2020. Across all open-market trades the lifetime net is +$25.6K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

9

Lifetime Open-Market Net

$25.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Aptose Biosciences Inc. (APTO) Delisted Sr VP & Chief Medical Officer 244 $1.71 $417 $25.6K 8 2024-02-07

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-01 — Disp (D) −244 -$420
2024-02-07 Aptose Biosciences Inc. (APTO) Delisted Grant (A) — $0 EDGAR
2023-01-23 Aptose Biosciences Inc. (APTO) Delisted Grant (A) +100,000 $0 EDGAR
2022-01-20 Aptose Biosciences Inc. (APTO) Delisted Grant (A) — $0 EDGAR
2021-11-19 Aptose Biosciences Inc. (APTO) Delisted Buy (P) +10,000 $25.6K EDGAR
2021-08-23 Aptose Biosciences Inc. (APTO) Delisted Grant (A) — $0 EDGAR
2021-01-06 Aptose Biosciences Inc. (APTO) Delisted Grant (A) — $0 EDGAR
2020-02-03 Aptose Biosciences Inc. (APTO) Delisted Grant (A) — $0 EDGAR
2020-01-03 Aptose Biosciences Inc. (APTO) Delisted Grant (A) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.